| Q28298834 | A SALL4/MLL/HOXA9 pathway in murine and human myeloid leukemogenesis |
| Q34294097 | A multicenter phase I/II study of obatoclax mesylate administered as a 3- or 24-hour infusion in older patients with previously untreated acute myeloid leukemia |
| Q36681959 | A novel SATB1 binding site in the BCL2 promoter region possesses transcriptional regulatory function |
| Q28507053 | Evidence that the Pim1 kinase gene is a direct target of HOXA9 |
| Q40797140 | HOX proteins and leukemia. |
| Q42359419 | HOXA repression is mediated by nucleoporin Nup93 assisted by its interactors Nup188 and Nup205. |
| Q37129652 | HOXA9 is required for survival in human MLL-rearranged acute leukemias |
| Q37334008 | HOXA9 modulates its oncogenic partner Meis1 to influence normal hematopoiesis |
| Q24610579 | HOXA9 regulates miR-155 in hematopoietic cells |
| Q36403748 | Histone deacetylase activity is essential for the expression of HoxA9 and for endothelial commitment of progenitor cells |
| Q35025091 | Homeobox gene expression in acute myeloid leukemia is linked to typical underlying molecular aberrations |
| Q34439668 | Hox genes and their candidate downstream targets in the developing central nervous system |
| Q42770287 | HoxA9 regulated Bcl-2 expression mediates survival of myeloid progenitors and the severity of HoxA9-dependent leukemia |
| Q36986228 | Hoxa9 and Flt3 signaling synergistically regulate an early checkpoint in lymphopoiesis |
| Q33963281 | Hoxa9 immortalizes a granulocyte-macrophage colony-stimulating factor-dependent promyelocyte capable of biphenotypic differentiation to neutrophils or macrophages, independent of enforced meis expression |
| Q37163718 | Hoxb8 regulates expression of microRNAs to control cell death and differentiation. |
| Q24610737 | Identification and characterization of Hoxa9 binding sites in hematopoietic cells |
| Q24683719 | Increased islet apoptosis in Pdx1+/- mice |
| Q45873757 | LEDGF/p75 is dispensable for hematopoiesis but essential for MLL-rearranged leukemogenesis |
| Q24670084 | Loss of expression of the Hoxa-9 homeobox gene impairs the proliferation and repopulating ability of hematopoietic stem cells |
| Q28585869 | Loss-of-function Additional sex combs like 1 mutations disrupt hematopoiesis but do not cause severe myelodysplasia or leukemia |
| Q24550988 | MLL and CREB bind cooperatively to the nuclear coactivator CREB-binding protein |
| Q24646559 | MicroRNA-126 regulates HOXA9 by binding to the homeobox |
| Q34213539 | Oncogenic IL7R gain-of-function mutations in childhood T-cell acute lymphoblastic leukemia |
| Q40567162 | Protein kinase C-mediated phosphorylation of the leukemia-associated HOXA9 protein impairs its DNA binding ability and induces myeloid differentiation. |
| Q39753312 | Reduced proliferative capacity of hematopoietic stem cells deficient in Hoxb3 and Hoxb4. |
| Q28082027 | Role of HOXA9 in leukemia: dysregulation, cofactors and essential targets |
| Q28273918 | SALL4 is a key transcription regulator in normal human hematopoiesis |
| Q47221138 | Thrombopoietin, flt3-ligand and c-kit-ligand modulate HOX gene expression in expanding cord blood CD133 cells |
| Q37019912 | Toll-like receptor 9 and interferon-γ receptor signaling suppress the B-cell fate of uncommitted progenitors in mice |